CAROL D. KARP

Ms. Karp has served as our Chief Regulatory Officer since 2016. Prior to joining Prothena, she was an independent regulatory consultant to biotechnology and pharmaceutical companies. From 2013 to 2014, she was Senior Vice President, Regulatory Affairs and Compliance at Esperion Therapeutics, Inc., and from 2010-2013 she was Vice President, Head of Global Regulatory Affairs, Pharmacovigilance & Risk Management at Janssen Alzheimer Immunotherapy, a Johnson & Johnson company. Previously, Ms. Karp held senior regulatory positions at CV Therapeutics, Inc., PowderJect Technologies, VIVUS, Cygnus and Janssen Pharmaceutica. Ms. Karp is Vice Chair of the Board of Trustees for the University of Rochester. Ms. Karp earned her BA in biology from the University of Rochester.